Tradestie Institutional Equity Comparison Engine

CAMP vs VOR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VOR Overall Edge

VOR Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus VOR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VOR sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VOR
CAMP N/M vs VOR N/M Fwd P/E
Growth & Margin Winner VOR
Op Margin -991.8% vs 0.0% ยท YoY +138.9% vs +0.0%
Momentum & Technical Winner VOR
1Y -2.4% vs +79.2% ยท 52W Pos 23% vs 59%
Options & Structure Winner VOR
UNCLASSIFIED (N/A IV) vs BREAKDOWN (6th %ile IV)
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
1M Return +27.39%
1Y Return -2.44%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
VOR NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$17.94
-5.43% 1D
Market Cap $1.2B
1M Return -0.55%
1Y Return +79.22%
Forward P/E N/M
Unified AI Score
51.5 / 100 HOLD
Tech 22.0 Fund 47.0 Flow 66.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAMP -2.44% VOR +79.22% Spread: +81.66 pp (VOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CAMP TTM Op. Margin: -991.8% VOR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CAMP vs VOR. Trailing 12-month operating profitability (CAMP -991.8% vs VOR 0.0%) and valuation multiples (CAMP N/M vs VOR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAMP (1) vs VOR (7)
Institutional Metric CAMP VOR Criterion Row Winner
Market Capitalization Scale $238.5M $1.2B Larger Scale VOR
Trailing P/E Ratio Valuation N/M 0.1x Lower Multiple VOR
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +138.9% +0.0% Higher Growth CAMP
Operating Margin (TTM) Profitability -991.8% 0.0% Higher Margin VOR
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -146.1% -125.4% Higher ROE VOR
52-Week Range Position Momentum 23% ($3โ€“$8) 59% ($6โ€“$26) Stronger Trend VOR
Beta / 30D Volatility Risk Regime 1.35ฮฒ ยท 94% Vol 1.94ฮฒ ยท 63% Vol Lower Realized Risk VOR
Unified Institutional Score Composite Signal 43.9 / 100 (HOLD) 51.5 / 100 (HOLD) Higher Composite VOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAMP vs VOR Buy Guide
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VOR BREAKDOWN
53d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAMP nor VOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.